MarketBeat reported consensus rating for Hikma Pharmaceuticals, while Jefferies increased its target price and gave a buy rating. Berenberg Bank reaffirmed its buy rating, and Citigroup restated a buy rating.
2 reports, 2 independent
Updated Mon 00:00
No new developments lately
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MarketBeat reported consensus rating for Hikma Pharmaceuticals, while Jefferies increased its target price and gave a buy rating. Berenberg Bank reaffirmed its buy rating, and Citigroup restated a buy rating.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Hikma Pharmaceuticals
UK-headquartered pharmaceutical company
Nothing else this week.
-
MarketBeat
American personal finance blog
-
Jefferies Financial Group
American financial services company
-
Berenberg Bank
German private bank based in Hamburg
Related events
- Analyst rating updates for Krystal Biotech, including a buy rating from TD Cowen and a consensus rating from MarketBeat.
- MarketBeat provided consensus rating data on Navios Maritime Partners LP, while Jefferies Financial Group assumed coverage and issued a buy rating.
- Global Mofy AI Limited was listed on the stock exchange and received a consensus rating from MarketBeat.
- MarketBeat provided stock rating data as Berenberg Bank cut its price target and Jefferies issued a buy rating report for LondonMetric Property Plc.
- Berenberg Bank reaffirmed a buy rating on Greencore Group, with MarketBeat aggregating the consensus rating data on May 27, 2026.